Abstract
The current sociocultural pressures to re-examine structural racism in society and in medicine have inspired researchers to question the assumptions that underpin clinical research and to more deliberately ask questions about the disparities in cancer outcomes based on race or ethnicity with a more intersectional lens.1 Sumit Gupta and colleagues2 present a provocative study on racial and ethnic disparities in survival outcomes in children with acute lymphocytic leukaemia who participated in Children's Oncology Group clinical trials between 2004 and 2019, showing that racial disparities in the outcome of acute lymphocytic leukaemia persist, despite overall advances in its management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
